Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate fromSubject ▲
 28.5.2019Mylan Ireland Limited (MNY)89680Letromyl (tbl flm 30x2,5 mg (blis.PVC/PVDC/Al))30.6.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80003Irbesartan Actavis 150 mg (tbl flm 84x150 mg (blis.PVC/PVDC/Al))24.1.2019Z
 15.4.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)78211Irinotecan medac 20 mg/ml (con inf 1x5 ml/100 mg (liek.inj.skl.hnedá))1.9.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80013Irbesartan Actavis 300 mg (tbl flm 28x300 mg (blis.PVC/PVDC/Al))25.4.2019Z
 30.5.2019CHEPLAPHARM Arzneimittel GmbH (CEP-1)13730Visudyne 15 mg prášok na infúzny roztok (plv ifo 1x15 mg (liek.skl.))1.8.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80019Irbesartan Actavis 300 mg (tbl flm 30x300 mg (fľ.HDPE))25.4.2019Z
 21.5.2019GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)2365APANADOL PRE DETI JAHODA 24 mg/ml (sus por 1x100 ml (fľ.PET hnedá+dáv.aplikátor-povolenie uvádzať na trh končí dňa 30.06.2019))30.6.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80020Irbesartan Actavis 300 mg (tbl flm 60x300 mg (fľ.HDPE))15.12.2019Z
 26.4.2019Mylan Ireland Limited (MNY)06663Omeprazol Mylan 20 mg (cps end 100x20 mg (blis.Al/PA/PVC))30.4.2019Z
 26.4.2019Mylan Ireland Limited (MNY)06658Omeprazol Mylan 20 mg (cps end 30x20 mg (blis.Al/PA/PVC))30.4.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80016Irbesartan Actavis 300 mg (tbl flm 84x300 mg (blis.PVC/PVDC/Al))1.10.2019Z
 15.5.2019GALDERMA INTERNATIONAL (GAD)5013BMirvaso 3 mg/g gél (gel 1x10 g (tuba PE/EAA kopolymér/Al/EAA kopolymér/PE))20.5.2019Z
 13.5.2019Egis Pharmaceuticals PLC (EGI)84648Hotemin 10 mg/g krém (crm der 1x50 g/0,5 g (tuba Al))1.7.2019Z
 2.5.2019Sandoz Pharmaceuticals d.d. (SAN-SLO-1)36467Vinorelbin "Ebewe" 10 mg/ ml infúzny koncentrát (con inf 1x5 ml/50 mg (liek.inj.skl.))15.5.2019Z
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)51228Paclimedac 6 mg/ml infúzny koncentrát (con inf 1x5 ml/30 mg (liek.inj.skl.))15.8.2019Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To